Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Interest Expenses (2017 - 2025)

Selectis Health's Interest Expenses history spans 14 years, with the latest figure at $205700.0 for Q3 2025.

  • For Q3 2025, Interest Expenses fell 56.36% year-over-year to $205700.0; the TTM value through Sep 2025 reached $1.3 million, down 43.81%, while the annual FY2024 figure was $2.0 million, 5.84% down from the prior year.
  • Interest Expenses for Q3 2025 was $205700.0 at Selectis Health, down from $225991.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $817353.0 in Q4 2021 and bottomed at $205700.0 in Q3 2025.
  • The 5-year median for Interest Expenses is $542667.0 (2025), against an average of $522124.2.
  • The largest annual shift saw Interest Expenses skyrocketed 69.84% in 2023 before it crashed 61.42% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $817353.0 in 2021, then dropped by 3.03% to $792604.0 in 2022, then fell by 14.23% to $679840.0 in 2023, then plummeted by 47.68% to $355717.0 in 2024, then crashed by 42.17% to $205700.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Interest Expenses are $205700.0 (Q3 2025), $225991.0 (Q2 2025), and $542667.0 (Q1 2025).